Angiogenesis Inducing Agents
-
Subject Areas on Research
-
Acidic stress promotes a glioma stem cell phenotype.
-
An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia.
-
Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.
-
Angiogenic, neurotrophic, and inflammatory system SNPs moderate the association between birth weight and ADHD symptom severity.
-
Angiogenin-mediated tRNA cleavage as a novel feature of stored red blood cells.
-
Basic fibroblast growth factor expression following surgical delay of rat transverse rectus abdominis myocutaneous flaps.
-
Circulating angiogenic factors and abnormal uterine artery Doppler velocimetry in the second trimester.
-
Current insights on the biology and clinical aspects of VEGF regulation.
-
Effect of low-fat diets on plasma levels of NF-κB-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer.
-
Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations.
-
Evolving revascularization approaches for myocardial ischemia.
-
Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
-
Growth factors for therapeutic angiogenesis in peripheral arterial disease.
-
Improved Angiogenesis in Response to Localized Delivery of Macrophage-Recruiting Molecules.
-
In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
-
Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2.
-
Mast cell tryptase: a new biomarker in patients with stable coronary artery disease.
-
Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy.
-
Molecular approaches for the treatment of atherosclerosis.
-
Non-viral DNA delivery from porous hyaluronic acid hydrogels in mice
-
Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance.
-
Recombinant human platelet-derived growth factor-BB and beta-tricalcium phosphate (rhPDGF-BB/β-TCP): an alternative to autogenous bone graft.
-
Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival.
-
The CXC chemokine cCAF stimulates precocious deposition of ECM molecules by wound fibroblasts, accelerating development of granulation tissue.
-
Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A.
-
Utilizing an interim futility analysis of the OVAL study (VB-111-701/GOG 3018) for potential reduction of risk: A phase III, double blind, randomized controlled trial of ofranergene obadenovec (VB-111) and weekly paclitaxel in patients with platinum resistant ovarian cancer.
-
Keywords of People